DJIA 17,743.91 113.64 0.64%
NASDAQ 5,101.74 12.54 0.25%
S&P 500 2,104.95 11.70 0.56%
market minute promo

Celgene (NASDAQ: CELG)

133.70 -1.72 (-1.27%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CELG $133.70 -1.27%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $136.33
Previous Close $135.42
Daily Range $133.78 - $136.40
52-Week Range $83.16 - $140.72
Market Cap $106.0B
P/E Ratio 51.30
Dividend (Yield) $0.00 (0.0%)
Volume 1,618,435
Average Daily Volume 5,151,943
Current FY EPS $4.22




Drug Makers

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary

Amp Up Your Portfolio With These Biotech Stocks

Gilead Sciences and Celgene offer growth at a reasonable price.

Today's Market: Names Riding Momentum To All-Time Highs, Earnings To Focus On

Is More M&A On The Way For Large-Cap Biotechs?

NantKwest Inc.: Our IPO Pick Of The Week

What To Expect From Gilead's 2Q Earnings: The Theory Behind The Madness

3 Big Biotech Buybacks That Investors Should Love

Big biotech companies are flush with cash and are using it to reward shareholders. Here are three companies that are spending big on share buybacks.

Forget Biogen, Buy These Promising Biotech Stocks Instead - Analyst Blog

Morgan Stanley Raises Price Target On Celgene, Still Highlights Several Risks

Cramer -- Be Careful Buying GrubHub, Biogen Is a Battleground

Short Sellers Back Off Major Biotechs

See More CELG News...

CELG's Top Competitors

CELG $133.70 (-1.27%)
Current stock: CELG
AMGN $171.56 (-0.68%)
Current stock: AMGN
GILD $116.49 (3.02%)
Current stock: GILD
$0.00 (0.00%)
Current stock: